Completed OBSERVATIONAL NCT06141343

A Study of the Next-generation Probiotic, Veillonella Atypica FB0054 vs Placebo (ProjectV)

Project V - A Randomized Controlled Prospective Study of the Next-generation Probiotic, Veillonella Atypica FB0054, vs Placebo in Healthy Adults

Sponsor: FitBiomics, Inc.

Conditions Fatigue

Interventions Placebo Veillonella atypica FB0054

Updated 3 times since 2023 Last updated: Nov 15, 2023 Started: Aug 1, 2023 Primary completion: Nov 7, 2023 Completion: Nov 7, 2023

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Fatigue, this trial is completed. The trial is conducted by FitBiomics, Inc. and has accumulated 3 data snapshots since 2023. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

3 versions recorded

Sep 2024 — Present [monthly]

Completed
Jul 2024 — Sep 2024 [monthly]

Completed
Dec 2023 — Jul 2024 [monthly]

Completed

First recorded

Aug 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

FitBiomics, Inc.
People Science, Inc.

Data source: FitBiomics, Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New York, United States